Apples and Oranges: Comparative Effectiveness Research in TMS for Depression

We will review recent clinical trials in depression comparing TMS with antidepressant medications.

You are invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series, Apples and Oranges: Comparative Effectiveness Research in TMS for Depression, presented by Mehmet Dokucu, MD, PhD, DFAPA.

Although not labeled as such by the FDA, TMS is considered a third line treatment by many practitioners and health insurance company policies.  Earlier referral to TMS is not commonly practiced but may be non-inferior to or superior to medication switches or augmentation.  Our field lacked trials that compared different modalities of treatment in parallel with TMS until recently, which is the subject of this webinar.
The core aspect of this webinar will be reviewing two very recent articles that compare TMS to antidepressant medications. We will also review basic concepts of non-inferiority trials and meta-analyses.

 

At the end of this presentation, attendees will be able to:

  1. Understand "head-to-head" trials and meta-analyses research
  2. Review and understand recent comparative articles on TMS
  3. Review and understand the current and future placement of TMS in the treatment algorithms of depression

One hour CME credit is available - Click here for CE Language

Take advantage of our live Q&A session at the conclusion of the webinar.

Date/Time: 
USA - October 1, 2024 at 8:00pm EDT | 5:00pm PDT
UK- October 2, 2024 at 1:00am BST
Australia- October 2, 2024 at 10:00am AEDT

Format: Live Webinar

Cost: Members: $25 | Non-members $50 | Trainee Members FREE

Can't make this time and date? All Grand Rounds are recorded and available On-Demand to all registered attendees. Recordings are available Friday after the live event.


Speaker: Mehmet Dokucu, MD, PhD, DFAPA

Mehmet_0.jpg

Dr. Dokucu is a broadly trained neuroscientist (PhD) and academic psychiatrist (MD) with expertise in Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Consultation Liaison Psychiatry and Psycho-oncology. He was the founding director of the Transcranial Magnetic Stimulation program at Northwestern Medicine in Chicago. He is currently an Associate Professor of Psychiatry at Dartmouth Geisel School of Medicine and he currently directs the Mood Disorders and Interventional Psychiatry Program at Dartmouth Hitchcock Medical Center.


When
October 1st, 2024 from  5:00 PM to  6:00 PM
Location
United States
Contact
Phone: info@clinicaltmssociety.org
Event Fee(s)
Fee Level